Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls

Johanna Eriksson; Vadim Le Joncour; Tiina Jahkola; Susanna Juteau; Pirjo Laakkonen; Olli Saksela; Erkki Hölttä

doi:10.1002/1878-0261.12649

Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls

Johanna Eriksson, Vadim Le Joncour, Tiina Jahkola, Susanna Juteau, Pirjo Laakkonen, Olli Saksela, Erkki Hölttä

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Molecular oncology
Volym	14
Nummer	4
Sidor (från-till)	742-762
Antal sidor	21
ISSN	1574-7891
DOI	https://doi.org/10.1002/1878-0261.12649
Status	Publicerad - apr. 2020
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3122 Cancersjukdomar

Åtkomst av dokument

10.1002/1878-0261.12649Licens: CC BY

1878-0261.12649Accepterat manuskript från författare, 31,2 MBLicens: CC BY

Citera det här

@article{ad8d3dc7a6f54b2da81ca5ae36a2b33e,

title = "Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls",

keywords = "3122 Cancers, melanoma, invasion, prognosis, P4HA1, CTHRC1, DECARBOXYLASE, COLLAGEN, DEATH, RHOC, CANCER, HYPOXIA SIGNATURES, GROWTH, EXPRESSION",

author = "Johanna Eriksson and {Le Joncour}, Vadim and Tiina Jahkola and Susanna Juteau and Pirjo Laakkonen and Olli Saksela and Erkki H{\"o}ltt{\"a}",

year = "2020",

month = apr,

doi = "10.1002/1878-0261.12649",

language = "English",

volume = "14",

pages = "742--762",

journal = "Molecular oncology",

issn = "1574-7891",

publisher = "Wiley",

number = "4",

}

Eriksson, J , Le Joncour, V , Jahkola, T , Juteau, S , Laakkonen, P , Saksela, O & Hölttä, E 2020, 'Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls', Molecular oncology, vol. 14, nr. 4, s. 742-762. https://doi.org/10.1002/1878-0261.12649

Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls. / Eriksson, Johanna ; Le Joncour, Vadim ; Jahkola, Tiina et al.

I: Molecular oncology, Vol. 14, Nr. 4, 04.2020, s. 742-762.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

TY - JOUR

T1 - Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls

AU - Eriksson, Johanna

AU - Le Joncour, Vadim

AU - Jahkola, Tiina

AU - Juteau, Susanna

AU - Laakkonen, Pirjo

AU - Saksela, Olli

AU - Hölttä, Erkki

PY - 2020/4

Y1 - 2020/4

KW - 3122 Cancers

KW - melanoma

KW - invasion

KW - prognosis

KW - P4HA1

KW - CTHRC1

KW - DECARBOXYLASE

KW - COLLAGEN

KW - DEATH

KW - RHOC

KW - CANCER

KW - HYPOXIA SIGNATURES

KW - GROWTH

KW - EXPRESSION

U2 - 10.1002/1878-0261.12649

DO - 10.1002/1878-0261.12649

M3 - Article

VL - 14

SP - 742

EP - 762

JO - Molecular oncology

JF - Molecular oncology

SN - 1574-7891

IS - 4

ER -